DNB Asset Management AS decreased its position in shares of Cigna Corp (NYSE:CI) by 1.3% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 683,092 shares of the health services provider’s stock after selling 8,967 shares during the period. Cigna accounts for 1.2% of DNB Asset Management AS’s holdings, making the stock its 16th biggest position. DNB Asset Management AS owned 0.18% of Cigna worth $107,621,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. FMR LLC raised its holdings in shares of Cigna by 21.6% in the first quarter. FMR LLC now owns 12,229,261 shares of the health services provider’s stock worth $1,966,710,000 after buying an additional 2,171,463 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Cigna by 61.3% in the fourth quarter. Geode Capital Management LLC now owns 4,939,173 shares of the health services provider’s stock worth $936,405,000 after buying an additional 1,876,556 shares during the last quarter. Boston Partners raised its holdings in shares of Cigna by 34.7% in the first quarter. Boston Partners now owns 4,895,908 shares of the health services provider’s stock worth $787,360,000 after buying an additional 1,261,911 shares during the last quarter. Veritas Asset Management LLP raised its holdings in shares of Cigna by 3.3% in the first quarter. Veritas Asset Management LLP now owns 4,605,129 shares of the health services provider’s stock worth $740,597,000 after buying an additional 146,675 shares during the last quarter. Finally, Barrow Hanley Mewhinney & Strauss LLC raised its holdings in shares of Cigna by 179.2% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 4,456,861 shares of the health services provider’s stock worth $846,447,000 after buying an additional 2,860,291 shares during the last quarter. 87.94% of the stock is owned by institutional investors.
CI has been the subject of a number of research analyst reports. ValuEngine cut shares of XCel Brands from a “sell” rating to a “strong sell” rating in a report on Tuesday. Morgan Stanley set a $207.00 price target on shares of Alibaba Group and gave the stock a “buy” rating in a report on Friday, July 12th. Citigroup raised shares of Atara Biotherapeutics from a “sell” rating to a “neutral” rating and raised their price target for the stock from $23.00 to $24.00 in a report on Monday, June 3rd. Goldman Sachs Group raised shares of Puxin from a “neutral” rating to a “buy” rating and raised their price target for the stock from $51.00 to $56.00 in a report on Friday, May 3rd. Finally, Barclays set a $24.00 price target on shares of Tenet Healthcare and gave the stock a “hold” rating in a report on Wednesday, April 17th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. Cigna presently has a consensus rating of “Buy” and an average price target of $217.40.
Cigna (NYSE:CI) last released its quarterly earnings results on Thursday, May 2nd. The health services provider reported $3.90 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.74 by $0.16. The company had revenue of $33.43 billion for the quarter, compared to analyst estimates of $32.79 billion. Cigna had a net margin of 4.11% and a return on equity of 14.23%. The firm’s revenue was up 192.9% on a year-over-year basis. During the same quarter last year, the business earned $4.11 earnings per share. Equities analysts predict that Cigna Corp will post 16.52 EPS for the current year.
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
See Also: Trade War
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.